Strides Pharma to Procure Solar Power from AMPIN’s Project in Chennai

Strides will acquire a 2.48% stake in AMPIN Energy C&I One  

October 28, 2024

/ Tina Freese
/ Finance and M&A, Solar
thumbnail

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights


Bengaluru-based pharmaceutical company Strides Pharma Science has announced an investment of ₹16.1 million (~$191,495) to acquire a 2.48% stake in AMPIN Energy C&I One on a fully diluted basis to set up captive solar power projects in Tamil Nadu.

MERCOM Insider

Where clean energy's most influential leaders get their intelligence

Exclusive reporting, market intelligence, and insider access that shapes billion-dollar decisions in renewable energy and clean technology.

Already have an account? Sign In

Register for free

thumbnail

Tina Freese

More articles from Tina Freese.
investmentRenewable EnergySharesSolar Projectstrides pharma company
PREVALL POSTSNEXT

RELATED POSTS

Get the most relevant India solar and clean energy news.

RECENT POSTS